CRISPR/Cas9系统与心脏病学基因组编辑的可能性 - Suppr

The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology.

作者信息

Arend Marcela Corso, Pereira Jessica Olivaes, Markoski Melissa Medeiros

机构信息

Laboratório de Cardiologia Molecular e Celular, Instituto de Cardiologia, Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.

出版信息

Arq Bras Cardiol. 2017 Jan;108(1):81-83. doi: 10.5935/abc.20160200.

DOI:10.5935/abc.20160200

PMID:28146210

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5245852/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24bf/5245852/fc4ab906ee14/abc-108-01-0081-g01.jpg

相似文献

The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology.

Arq Bras Cardiol. 2017 Jan;108(1):81-83. doi: 10.5935/abc.20160200.

CRISPR (Clustered Regularly Interspaced Palindromic Repeat)/Cas9 System: A Revolutionary Disease-Modifying Technology.

Circulation. 2016 Sep 13;134(11):777-9. doi: 10.1161/CIRCULATIONAHA.116.024007.

Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.

J Am Coll Cardiol. 2017 Dec 5;70(22):2808-2821. doi: 10.1016/j.jacc.2017.10.002.

Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

Hum Gene Ther. 2015 Jul;26(7):443-51. doi: 10.1089/hum.2015.074.

[The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases].

Med Sci (Paris). 2015 Nov;31(11):1014-22. doi: 10.1051/medsci/20153111016. Epub 2015 Nov 17.

Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.

Circ Res. 2017 Mar 3;120(5):876-894. doi: 10.1161/CIRCRESAHA.116.309727.

[Rare diseases and the CRISPR technology...].

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):125-9. doi: 10.1684/abc.2016.1131.

New research on using CRISPR/Cas9 to treat HIV.

AIDS. 2017 Feb 20;31(4):N7. doi: 10.1097/QAD.0000000000001294.

[The outlook for gene therapy in cardiology].

Ter Arkh. 1997;69(2):71-6.

CRISPR/Cas9 for genome editing: progress, implications and challenges.

Hum Mol Genet. 2014 Sep 15;23(R1):R40-6. doi: 10.1093/hmg/ddu125. Epub 2014 Mar 20.

本文引用的文献

Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration.

Stem Cells Int. 2016;2016:2171035. doi: 10.1155/2016/2171035. Epub 2016 Jan 5.

Variations in the Prevalence of Risk Factors for Coronary Artery Disease in Rio Grande do Sul-Brazil: A Comparative Analysis between 2002 and 2014.

Arq Bras Cardiol. 2015 Dec;105(6):573-9. doi: 10.5935/abc.20150127. Epub 2015 Oct 27.

CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases.

Mol Neurodegener. 2015 Aug 4;10:35. doi: 10.1186/s13024-015-0031-x.

Fanconi anemia gene editing by the CRISPR/Cas9 system.

Hum Gene Ther. 2015 Feb;26(2):114-26. doi: 10.1089/hum.2014.111.

Genomic editing tools to model human diseases with isogenic pluripotent stem cells.

Stem Cells Dev. 2014 Nov 15;23(22):2673-86. doi: 10.1089/scd.2014.0167. Epub 2014 Oct 7.

Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Circ Res. 2014 Aug 15;115(5):488-92. doi: 10.1161/CIRCRESAHA.115.304351. Epub 2014 Jun 10.

CRISPR-Cas systems for editing, regulating and targeting genomes.

Nat Biotechnol. 2014 Apr;32(4):347-55. doi: 10.1038/nbt.2842. Epub 2014 Mar 2.

Effective gene targeting in rabbits using RNA-guided Cas9 nucleases.

J Mol Cell Biol. 2014 Feb;6(1):97-9. doi: 10.1093/jmcb/mjt047. Epub 2014 Jan 8.

Network topology reveals key cardiovascular disease genes.

PLoS One. 2013 Aug 15;8(8):e71537. doi: 10.1371/journal.pone.0071537. eCollection 2013.

Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9. doi: 10.1073/pnas.1308335110. Epub 2013 Aug 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology.

Arq Bras Cardiol. 2017 Jan;108(1):81-83. doi: 10.5935/abc.20160200.

CRISPR (Clustered Regularly Interspaced Palindromic Repeat)/Cas9 System: A Revolutionary Disease-Modifying Technology.

Circulation. 2016 Sep 13;134(11):777-9. doi: 10.1161/CIRCULATIONAHA.116.024007.

Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.

J Am Coll Cardiol. 2017 Dec 5;70(22):2808-2821. doi: 10.1016/j.jacc.2017.10.002.

Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

Hum Gene Ther. 2015 Jul;26(7):443-51. doi: 10.1089/hum.2015.074.

[The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases].

Med Sci (Paris). 2015 Nov;31(11):1014-22. doi: 10.1051/medsci/20153111016. Epub 2015 Nov 17.

Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.

Circ Res. 2017 Mar 3;120(5):876-894. doi: 10.1161/CIRCRESAHA.116.309727.

[Rare diseases and the CRISPR technology...].

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):125-9. doi: 10.1684/abc.2016.1131.

New research on using CRISPR/Cas9 to treat HIV.

AIDS. 2017 Feb 20;31(4):N7. doi: 10.1097/QAD.0000000000001294.

[The outlook for gene therapy in cardiology].

Ter Arkh. 1997;69(2):71-6.

CRISPR/Cas9 for genome editing: progress, implications and challenges.

Hum Mol Genet. 2014 Sep 15;23(R1):R40-6. doi: 10.1093/hmg/ddu125. Epub 2014 Mar 20.

本文引用的文献

Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration.

Stem Cells Int. 2016;2016:2171035. doi: 10.1155/2016/2171035. Epub 2016 Jan 5.

Variations in the Prevalence of Risk Factors for Coronary Artery Disease in Rio Grande do Sul-Brazil: A Comparative Analysis between 2002 and 2014.

Arq Bras Cardiol. 2015 Dec;105(6):573-9. doi: 10.5935/abc.20150127. Epub 2015 Oct 27.

CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases.

Mol Neurodegener. 2015 Aug 4;10:35. doi: 10.1186/s13024-015-0031-x.

Fanconi anemia gene editing by the CRISPR/Cas9 system.

Hum Gene Ther. 2015 Feb;26(2):114-26. doi: 10.1089/hum.2014.111.

Genomic editing tools to model human diseases with isogenic pluripotent stem cells.

Stem Cells Dev. 2014 Nov 15;23(22):2673-86. doi: 10.1089/scd.2014.0167. Epub 2014 Oct 7.

Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Circ Res. 2014 Aug 15;115(5):488-92. doi: 10.1161/CIRCRESAHA.115.304351. Epub 2014 Jun 10.

CRISPR-Cas systems for editing, regulating and targeting genomes.

Nat Biotechnol. 2014 Apr;32(4):347-55. doi: 10.1038/nbt.2842. Epub 2014 Mar 2.

Effective gene targeting in rabbits using RNA-guided Cas9 nucleases.

J Mol Cell Biol. 2014 Feb;6(1):97-9. doi: 10.1093/jmcb/mjt047. Epub 2014 Jan 8.

Network topology reveals key cardiovascular disease genes.

PLoS One. 2013 Aug 15;8(8):e71537. doi: 10.1371/journal.pone.0071537. eCollection 2013.

Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9. doi: 10.1073/pnas.1308335110. Epub 2013 Aug 5.

The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献